News

Taiwan Fund, Inc. Reveals Key Financial Performance Data

Taiwan Fund, Inc. Reveals Key Financial Performance Data

Taiwan Fund, Inc. Shares Financial Insights for the Latest Quarter

The Taiwan Fund, Inc. (the "Fund") (NYSE: TWN) has recently unveiled important details about its investment performance during the most recent three-month period. The focus of this report is to provide shareholders and interested parties with a clear understanding of the Fund's financial standing and operational outcomes.

Net Asset Value and Share Price Update

As of the end of the reporting period, the Fund reported a net asset value per share of $52.97. This indicates a drop of $0.81 from the previously reported value of $53.78. It's worth noting that the Fund experienced a total return of -1.51%, in contrast to the TAIEX Total Return Index, which recorded a slightly better return of -1.34%.

Detailed Breakdown of Financial Performance

The Fund's trading shares on the New York Stock Exchange closed at $42.63, reflecting a decline of $2.10 from its earlier share price of $44.73. This shift also increased the discount to net asset value per share from 16.83% to 19.52%.

In terms of financial achievements, the Fund reported net realized gains of $3,115,096 from investments and foreign currency transactions for the quarter. However, it also faced a decrease in net unrealized appreciation amounting to $9,851,700, indicating fluctuating market conditions affecting its portfolio.

Key Financial Figures for the Quarter

During this quarter, the net investment loss was recorded at $27,963, which reflects the Fund's operational expenses in relation to its income from dividends and securities lending. The following table encapsulates the crucial financial metrics:

Financial Data Overview

Here is a summary of significant financial performance indicators for the quarter:

  • Total Net Assets: $347,890,875
  • Gross Investment Income Per Share: $0.12
  • Net Investment Income (Loss) Per Share: ($0.00)
  • Net Realized Gain (Loss) on Investments: $3,115,096
  • Net Unrealized Appreciation (Depreciation) on Investments: ($9,851,700)
  • Total Increase (Decrease) in Net Assets Resulting from Operations: ($6,764,566) Per Share: ($1.03)

Investment Strategy and Future Prospects

The Fund operates as a diversified closed-end investment company, predominantly aiming for substantial capital growth through strategic investments in equity securities that are listed on the Taiwan Stock Exchange. This focused approach aims to maximize shareholder value over the long term.

Given the current economic climate and market fluctuations, the management will continue to monitor and adapt its investment strategy to enhance performance and safeguard investor interests.

Contact and Further Information

For more comprehensive details on the Fund's portfolio and investment strategies, shareholders are encouraged to visit the Fund's official website or reach out through the provided contact information. Here are the relevant contact details:

Contact Person: Brian F. Link, Secretary
Phone: 1-800-426-5523

The Taiwan Fund, Inc. remains committed to providing transparency and detailed financial insights to its shareholders as part of its ongoing dedication to investment excellence.

Frequently Asked Questions

What is the net asset value per share for the Fund?

The net asset value per share reported is $52.97 as of the latest reporting period.

What were the total realized gains for the quarter?

The Fund achieved net realized gains amounting to $3,115,096 from both investments and foreign currency transactions.

How has the Fund's share price changed recently?

The Fund's share price was $42.63 at the close of the reporting period, down by $2.10 since the previous reporting date.

How does the Fund's return compare to the TAIEX Total Return Index?

The Fund's total return was -1.51%, while the TAIEX Total Return Index returned -1.34% during the same period.

What is the primary investment strategy of the Fund?

The Fund focuses on long-term capital appreciation primarily through investments in equity securities listed on the Taiwan Stock Exchange.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 6

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 7

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 7

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 6

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 10

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 6

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 7

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading

Top 5 Most Recently Viewed Articles

Rapid Micro Biosystems Unveils Presentation Plans for 2025 Conference

Updated Category News Views 153

Rapid Micro Biosystems Announces Upcoming Presentation Rapid Micro Biosystems, Inc. (NASDAQ: RPID) is thrilled to share that it will present at the prestigious 43rd Annual J.P. Morgan Healthcare Conference. This event offers a significant platform for the company to showcase its innovative approaches in the life sciences sector, with a focus on automation solutions that...

Continue Reading
Stock Strategies: Insights from Top Traders on CNBC

Updated Category News Views 371

Latest Stock Picks from CNBC’s Final Trades In a recent episode of CNBC’s popular segment, traders shared their choices for stocks that could see significant movement. Among those highlighted was Agnico Eagle Mines Limited (AEM), with Kevin Simpson from Capital Wealth Planning citing expectations for robust quarterly earnings, indicating a fifth consecutive quarter of...

Continue Reading
Investigating Claims for Investors of Constellation Brands

Updated Category News Views 136

Understanding the Investor Landscape Regarding Constellation Brands Faruqi & Faruqi, LLP, a prominent name in national securities litigation, is currently investigating potential claims for investors who have recently experienced significant losses with Constellation Brands, Inc. (NYSE: STZ). Investors who incurred losses exceeding $50,000 during the specified period are...

Continue Reading
Anticipating the Crew-8 Splashdown: What to Expect

Updated Category News Views 261

Anticipating the Crew-8 Splashdown: What to Expect NASA, in collaboration with SpaceX, is gearing up for an exciting moment as they prepare for the return of the Crew-8 mission. This mission, featuring astronauts from NASA and a cosmonaut from Roscosmos, marks a significant milestone as they conclude their seven-month expedition aboard the International Space Station....

Continue Reading
AEON Biopharma Tackles NYSE Compliance Challenge Head On

Updated Category News Views 113

AEON Biopharma Faces NYSE American Compliance Notice AEON Biopharma, Inc. (NYSE: AEON) based in Irvine, California, has recently encountered a situation that affects its compliance with NYSE American’s listing standards. The company, known for its pioneering work in the biopharmaceutical sector, focuses on developing a botulinum toxin complex. This situation is centered...

Continue Reading